Skip to Content
Merck
  • XRN2 is required for the degradation of target RNAs by RNase H1-dependent antisense oligonucleotides.

XRN2 is required for the degradation of target RNAs by RNase H1-dependent antisense oligonucleotides.

Biochemical and biophysical research communications (2015-07-15)
Shin-Ichiro Hori, Tsuyoshi Yamamoto, Satoshi Obika
ABSTRACT

Antisense oligonucleotides (ASOs) can suppress the expression of a target gene by cleaving pre-mRNA and/or mature mRNA via RNase H1. Following the initial endonucleolytic cleavage by RNase H1, the target RNAs are degraded by a mechanism that is poorly understood. To better understand this degradation pathway, we depleted the expression of two major 5' to 3' exoribonucleases (XRNs), named XRN1 and XRN2, and analyzed the levels of 3' fragments of the target RNAs in vitro. We found that the 3' fragments of target pre-mRNA generated by ASO were almost completely degraded from their 5' ends by nuclear XRN2 after RNase H1-mediated cleavage, whereas the 3' fragments of mature mRNA were partially degraded by XRN2. In contrast to ASO, small interference RNA (siRNA) could reduce the expression level of only mature mRNA, and the 3' fragment was degraded by cytoplasmic XRN1. Our findings indicate that the RNAs targeted by RNase H1-dependent ASO are rapidly degraded in the nucleus, contrary to the cytoplasmic degradation pathway mediated by siRNA.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
MISSION® esiRNA, targeting mouse Xrn1
Sigma-Aldrich
MISSION® esiRNA, targeting mouse Rnaseh1
Sigma-Aldrich
MISSION® esiRNA, targeting human XRN2
Sigma-Aldrich
MISSION® esiRNA, targeting human RNASEH1
Sigma-Aldrich
MISSION® esiRNA, targeting mouse Xrn2
Sigma-Aldrich
MISSION® esiRNA, targeting human XRN1